Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
46.02
-1.11 (-2.36%)
At close: Aug 15, 2025, 4:00 PM
46.18
+0.16 (0.35%)
After-hours: Aug 15, 2025, 7:59 PM EDT
Hims & Hers Health Revenue
Hims & Hers Health had revenue of $544.83M in the quarter ending June 30, 2025, with 72.61% growth. This brings the company's revenue in the last twelve months to $2.01B, up 88.69% year-over-year. In the year 2024, Hims & Hers Health had annual revenue of $1.48B with 69.33% growth.
Revenue (ttm)
$2.01B
Revenue Growth
+88.69%
P/S Ratio
5.04
Revenue / Employee
$1,230,017
Employees
1,637
Market Cap
10.40B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.48B | 604.51M | 69.33% |
Dec 31, 2023 | 872.00M | 345.08M | 65.49% |
Dec 31, 2022 | 526.92M | 255.04M | 93.81% |
Dec 31, 2021 | 271.88M | 123.12M | 82.77% |
Dec 31, 2020 | 148.76M | 66.20M | 80.18% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Walmart | 685.09B |
Costco Wholesale | 268.78B |
PepsiCo | 91.75B |
The Procter & Gamble Company | 84.28B |
Unilever | 70.19B |
Anheuser-Busch InBev | 58.52B |
The Coca-Cola Company | 47.06B |
Philip Morris International | 39.06B |
HIMS News
- 1 hour ago - HIMS' Transformation Into A Precision Health Platform - Seeking Alpha
- 1 day ago - US FTC investigating Hims & Hers over advertisements and cancellation practices, Bloomberg News reports - Reuters
- 1 day ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - PRNewsWire
- 3 days ago - Hims & Hers CEO sells $33 million in stock after a massive rally - Market Watch
- 4 days ago - Why is Novo Nordisk excluding Hims & Hers in its lawsuits over Wegovy copies? - Fast Company
- 4 days ago - As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims? - Reuters
- 8 days ago - Hims & Hers: A High-Risk Bet - Seeking Alpha
- 9 days ago - Hims & Hers: From Telehealth To Wellness Hub, The Bright Future - Seeking Alpha